We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

5 hedge funds and large institutions have $36K invested in InspireMD, Inc. Series B Warrants in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

14% less capital invested

Capital invested by funds: $42K → $36K (-$6K)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$13
2
UBS Group
UBS Group
Switzerland
+$1

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$438
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$35K – – –
SM
2
Sabby Management
Florida
$1K -$438 -364,809 -25%
UBS Group
3
UBS Group
Switzerland
– +$1 +1,100 +1%
Citadel Advisors
4
Citadel Advisors
Florida
– +$13 +11,059 New

NSPRZ Hedge Fund Activity: Q1 2019 in Review

5 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q1 2019, worth a combined $36K — down 14% from $42K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NSPRZ positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $13. The largest seller was Sabby Management, cutting an estimated $438.

  • 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q1 2019, up from 4 in Q4 2018.
  • Funds reported $36K of InspireMD, Inc. Series B Warrants stock for Q1 2019, down 14% quarter-over-quarter.
  • 1 fund opened new InspireMD, Inc. Series B Warrants positions in Q1 2019 and 0 closed out, a net change of +1 holder.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q1 2019 was Citadel Advisors, an estimated $13 added.
  • The largest InspireMD, Inc. Series B Warrants seller in Q1 2019 was Sabby Management, an estimated $438 sold.

Based on aggregated 13F filings for Q1 2019.